收藏切换
Research advances in the study of anticoagulant active molecules
收藏切换
PDF
Kang-jia SHENG1, 2, Yan GAO1, 2, Tao BAO1, 2, *, Si-cen WANG1, 2, *
Acta Pharmaceutica Sinica | 2023, 58(5) : 1103 - 1116
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(5): 1103-1116
Special Reports: Active Ingredients and Mechanism of Action of Traditional Chinese Medicine
Research advances in the study of anticoagulant active molecules
Full
Kang-jia SHENG1, 2, Yan GAO1, 2, Tao BAO1, 2, *, Si-cen WANG1, 2, *
Affiliations
  • 1. School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China
  • 2. Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis, Xi'an 710061, China
Published: 2023-05-12 doi: 10.16438/j.0513-4870.2022-1147
Outline
收藏切换

The incidence of thrombosis-induced cardiovascular diseases is increasing worldwide and poses a serious threat to human health. Three factors, slow speed of blood flow, hypercoagulable blood and vascular damage, have been considered to be causes of thrombosis. Antithrombotic drugs have been classified into three categories based on the mechanism of thrombosis, including anticoagulants, platelet inhibitors and fibrinolytics. The coagulation and anticoagulation systems have drawn increasing attention because of the important role they play in the process of thrombosis. Novel compounds with anticoagulant activity are now emerging, alleviating to some extent some of the problems associated with the clinical use of early approved thrombotic drugs, such as high bleeding risk, slow onset of action and narrow therapeutic windows. In this review, we initially describe the mechanisms of coagulation as well as thrombosis. Meanwhile, a wide range of bioactive compounds and potential antithrombotic candidates reported in recent years have been summarized. In addition, the structure-activity relationship of certain compounds has been discussed, expecting to facilitate the development of molecules with anticoagulant biological activity for the treatment of thrombotic diseases.

anticoagulant activity  /  antithrombotic activity  /  druggability evaluation  /  small molecule active substance  /  structure-activity relationship
Kang-jia SHENG, Yan GAO, Tao BAO, Si-cen WANG. Research advances in the study of anticoagulant active molecules[J]. Acta Pharmaceutica Sinica, 2023 , 58 (5) : 1103 -1116 . DOI: 10.16438/j.0513-4870.2022-1147
Year 2023 volume 58 Issue 5
PDF
211
90
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-1147
  • Receive Date:2022-10-28
  • Online Date:2025-11-21
  • Published:2023-05-12
Article Data
Affiliations
History
  • Received:2022-10-28
  • Revised:2023-02-15
Funding
Affiliations
    1. School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China
    2. Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis, Xi'an 710061, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-1147
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT